National laboratory-based surveillance system for antimicrobial resistance: a successful tool to support the control of antimicrobial resistance in the Netherlands
- PMID: 29162208
- PMCID: PMC5718398
- DOI: 10.2807/1560-7917.ES.2017.22.46.17-00062
National laboratory-based surveillance system for antimicrobial resistance: a successful tool to support the control of antimicrobial resistance in the Netherlands
Abstract
An important cornerstone in the control of antimicrobial resistance (AMR) is a well-designed quantitative system for the surveillance of spread and temporal trends in AMR. Since 2008, the Dutch national AMR surveillance system, based on routine data from medical microbiological laboratories (MMLs), has developed into a successful tool to support the control of AMR in the Netherlands. It provides background information for policy making in public health and healthcare services, supports development of empirical antibiotic therapy guidelines and facilitates in-depth research. In addition, participation of the MMLs in the national AMR surveillance network has contributed to sharing of knowledge and quality improvement. A future improvement will be the implementation of a new semantic standard together with standardised data transfer, which will reduce errors in data handling and enable a more real-time surveillance. Furthermore, the scientific impact and the possibility of detecting outbreaks may be amplified by merging the AMR surveillance database with databases from selected pathogen-based surveillance programmes containing patient data and genotypic typing data.
Keywords: ISIS-AR; Netherlands; antimicrobial resistance; surveillance.
Conflict of interest statement
Figures



Similar articles
-
Reflections on an evaluation of the Dutch Infectious diseases Surveillance Information System.Euro Surveill. 2008 Mar 13;13(11):8070. doi: 10.2807/ese.13.11.08070-en. Euro Surveill. 2008. PMID: 18768126
-
The barriers and facilitators of implementing a national laboratory-based AMR surveillance system in Cambodia: key informants' perspectives and assessments of microbiology laboratories.Front Public Health. 2023 Dec 21;11:1332423. doi: 10.3389/fpubh.2023.1332423. eCollection 2023. Front Public Health. 2023. PMID: 38179556 Free PMC article.
-
How a laboratory-based antimicrobial resistance (AMR) regional surveillance system can address large-scale and local AMR epidemiology: the MICRO-BIO experience.Front Public Health. 2024 Feb 12;12:1341482. doi: 10.3389/fpubh.2024.1341482. eCollection 2024. Front Public Health. 2024. PMID: 38410663 Free PMC article.
-
Unbiased antimicrobial resistance prevalence estimates through population-based surveillance.Clin Microbiol Infect. 2023 Apr;29(4):429-433. doi: 10.1016/j.cmi.2022.05.006. Epub 2022 May 18. Clin Microbiol Infect. 2023. PMID: 35595126 Review.
-
Setting up laboratory-based antimicrobial resistance surveillance in low- and middle-income countries: lessons learned from Georgia.Clin Microbiol Infect. 2021 Oct;27(10):1409-1413. doi: 10.1016/j.cmi.2021.05.027. Epub 2021 May 24. Clin Microbiol Infect. 2021. PMID: 34044149 Review.
Cited by
-
An Overview of the Recent Advances in Antimicrobial Resistance.Microorganisms. 2024 Sep 21;12(9):1920. doi: 10.3390/microorganisms12091920. Microorganisms. 2024. PMID: 39338594 Free PMC article. Review.
-
External quality assessment schemes in bacteriology support public health in Germany-results from 2006 to 2023.Front Mol Biosci. 2024 May 17;11:1395410. doi: 10.3389/fmolb.2024.1395410. eCollection 2024. Front Mol Biosci. 2024. PMID: 38828394 Free PMC article.
-
The importance of meropenem resistance, rather than imipenem resistance, in defining carbapenem-resistant Enterobacterales for public health surveillance: an analysis of national population-based surveillance.BMC Infect Dis. 2024 Feb 15;24(1):209. doi: 10.1186/s12879-024-09107-4. BMC Infect Dis. 2024. PMID: 38360618 Free PMC article.
-
Reducing antimicrobial use in livestock alone may be not sufficient to reduce antimicrobial resistance among human Campylobacter infections: an ecological study in the Netherlands.Epidemiol Infect. 2024 Nov 27;152:e148. doi: 10.1017/S0950268824001511. Epidemiol Infect. 2024. PMID: 39601656 Free PMC article.
-
Temporal trends in antimicrobial resistance of medically important pathogens on Curaçao.Antimicrob Resist Infect Control. 2024 Dec 18;13(1):151. doi: 10.1186/s13756-024-01499-x. Antimicrob Resist Infect Control. 2024. PMID: 39696523 Free PMC article.
References
-
- World Health Organisation (WHO). Antimicrobial resistance: global report on surveillance 2014. Geneva: WHO; 2014. Available from: http://www.who.int/drugresistance/documents/surveillancereport/en/
-
- World Health Organisation (WHO). World health day 2011. Geneva: WHO; 2011. Available from: http://www.who.int/mediacentre/news/statements/2011/whd_20110407/en/
-
- World Health Organisation (WHO). Antimicrobial resistance in the European Union and the world. Geneva: WHO; 2012. Available from: http://www.who.int/dg/speeches/2012/amr_20120314/en/
-
- Science and Technology Committee. Wednesday 23 January 2013 Meeting started at 10.12am, ended 11.11am. London: UK parliament; 2013. Available from: http://parliamentlive.tv/event/index/c7df492a-f492-4953-a9bf-2cba88857c82
-
- O’Neill J. Tackling drug-resistant infections globally: final report and recommendations. Review of antimicrobial resistance. London: HM Government and Wellcome trust; 2016. Available from: https://amr-review.org/sites/default/files/160518_Final%20paper_with%20c...
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials